Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03671083 · ClinicalTrials.gov registry record
Validation of Brain Function Assessment Algorithm for mTBI/Concussion
A clinical trial, sponsored by BrainScope Company.
- Completed
- Registry status
- 309
- Enrollment target
NCT03671083 is a clinical trial that has completed, run by BrainScope Company. The registered enrollment target is 309 participants.
The verdict
NCT03671083 has completed, sponsored by BrainScope Company.
- COMPLETED
- Registry status
- 309 participants
- Enrollment target
Study Summary
This study is Part 2 of data collection from 13-25 years old subject population for validation of previously derived algorithms. This data will be combined with that collected under NCT02957461 (Part 1 with subject age range 18-25 years) for the final analyses of validation of the algorithms.
Interventions
- DEVICE BrainScope Ahead 300iP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 309 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2019-03-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03671083
The ClinicalTrials.gov registry entry for NCT03671083 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 309 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BrainScope Company, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BrainScope Ahead 300iP is the first listed.
NCT03671083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03671083 about?
NCT03671083 is a clinical study titled "Validation of Brain Function Assessment Algorithm for mTBI/Concussion". This study is Part 2 of data collection from 13-25 years old subject population for validation of previously derived algorithms. This data will be combined with that collected under NCT02957461 (Part 1 with subject age range 18-25 years) for the final analyses of validation of the algorithms.
What is the current status of trial NCT03671083?
This trial is currently completed. The enrollment target is 309 participants. The study started on 2018-10-01. Estimated completion is 2019-03-29.
What interventions are being tested in trial NCT03671083?
The interventions under investigation include: BrainScope Ahead 300iP (DEVICE).
Who is sponsoring clinical trial NCT03671083?
This trial is sponsored by BrainScope Company, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.